Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Preperation of (99m)Tc labeled 5-fluorouracil as a potential diagnostic agent in advanced breast cancer: first clinical trial.

Dar UK, Khan IU, Javed M, Rasheed R, Mahmoud Z, Hyder SW, Bhatti SM, Anwar J.

Hell J Nucl Med. 2012 Jan-Apr;15(1):43-7.

PMID:
22413112
[PubMed - indexed for MEDLINE]
2.

Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy.

Kumar S, Kumar Mishra A, Chhikara BS, Chuttani K, Kumar Sharma R.

Hell J Nucl Med. 2008 May-Aug;11(2):91-5.

PMID:
18815662
[PubMed - indexed for MEDLINE]
3.

Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL.

Takahashi N, Yang DJ, Kohanim S, Oh CS, Yu DF, Azhdarinia A, Kurihara H, Zhang X, Chang JY, Kim EE.

Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):354-62. Epub 2006 Sep 22.

PMID:
17021817
[PubMed - indexed for MEDLINE]
4.

Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.

Bach-Gansmo T, Danielsson R, Saracco A, Wilczek B, Bogsrud TV, Fangberget A, Tangerud A, Tobin D.

J Nucl Med. 2006 Sep;47(9):1434-9. Erratum in: J Nucl Med. 2007 Apr;48(4):567.

PMID:
16954550
[PubMed - indexed for MEDLINE]
Free Article
5.

Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors.

Chen Y, Huang ZW, He L, Zheng SL, Li JL, Qin DL.

Appl Radiat Isot. 2006 Mar;64(3):342-7. Epub 2005 Nov 14.

PMID:
16290170
[PubMed - indexed for MEDLINE]
6.

Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping.

Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM.

Nucl Med Biol. 2003 Nov;30(8):805-10.

PMID:
14698783
[PubMed - indexed for MEDLINE]
7.

The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.

Wang F, Wang Z, Wu J, Qu W, Yao W, Zhao J, Liu Z.

Nucl Med Biol. 2008 Aug;35(6):665-71. doi: 10.1016/j.nucmedbio.2008.04.010. Epub 2008 Jun 30.

PMID:
18678351
[PubMed - indexed for MEDLINE]
8.

Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.

Zhang X, Chen X.

Appl Radiat Isot. 2007 Jan;65(1):70-8. Epub 2006 Sep 29.

PMID:
17011200
[PubMed - indexed for MEDLINE]
9.

PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

Thakur ML, Aruva MR, Gariepy J, Acton P, Rattan S, Prasad S, Wickstrom E, Alavi A.

J Nucl Med. 2004 Aug;45(8):1381-9.

PMID:
15299065
[PubMed - indexed for MEDLINE]
Free Article
10.

Development of 99mTc-5-fluorouracil as a potential tumor diagnostic agent.

Dar UK, Khan I, Javed M, Ali M, Hyder SW, Murad S, Anwar J.

Pak J Pharm Sci. 2013 Mar;26(2):333-7.

PMID:
23455204
[PubMed - indexed for MEDLINE]
11.

Biological evaluation of a technetium-99m-labeled integrated tropane-BAT and its piperidine congener as potential dopamine transporter imaging agents.

Kieffer DM, Vanbilloen HP, Cleynhens BJ, Terwinghe CY, Mortelmans L, Bormans GM, Verbruggen AM.

Nucl Med Biol. 2006 Jan;33(1):125-33.

PMID:
16459268
[PubMed - indexed for MEDLINE]
12.

99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.

Mukherjee A, Kothari K, Tóth G, Szemenyei E, Sarma HD, Környei J, Venkatesh M.

Nucl Med Biol. 2006 Jul;33(5):635-43.

PMID:
16843838
[PubMed - indexed for MEDLINE]
13.

Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.

Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.

Int J Pharm. 2009 Jun 22;375(1-2):75-83. doi: 10.1016/j.ijpharm.2009.04.018. Epub 2009 Apr 22.

PMID:
19393305
[PubMed - indexed for MEDLINE]
14.

Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial.

Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, Nadeem MA, Khan MA, Afzal MS, Ul-Haq I, Imran MB.

J Nucl Med. 2005 Apr;46(4):567-73.

PMID:
15809477
[PubMed - indexed for MEDLINE]
Free Article
15.

(99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.

Karczmarczyk U, Markiewicz A, Mikołajczak R, Lisiak E, Bilski M, Pietrzykowski J, Michalik J.

Nucl Med Rev Cent East Eur. 2004;7(2):107-12.

PMID:
15968595
[PubMed - indexed for MEDLINE]
16.

99m Tc-glycopeptide: synthesis, biodistribution and imaging in breast tumor-bearing rodents.

Wei IC, Tsao N, Huang YH, Ho YS, Wu CC, Yu DF, Yang DJ.

Appl Radiat Isot. 2008 Mar;66(3):320-31. Epub 2007 Oct 17.

PMID:
18036826
[PubMed - indexed for MEDLINE]
17.

Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.

Rennen HJ, Boerman OC, Oyen WJ, Corstens FH.

J Nucl Med. 2003 Sep;44(9):1502-9.

PMID:
12960199
[PubMed - indexed for MEDLINE]
Free Article
19.

Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.

Ogawa K, Mukai T, Inoue Y, Ono M, Saji H.

J Nucl Med. 2006 Dec;47(12):2042-7.

PMID:
17138748
[PubMed - indexed for MEDLINE]
Free Article
20.

Radioimmuno targetting (99m)technetium labeled anti-epidermal growth factor receptor monoclonal antibodies in experimental tumor models.

Meenakshi A, Ganesh V, Suresh Kumar R, Siva Kumar N.

Q J Nucl Med. 2003 Jun;47(2):139-44.

PMID:
12865874
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk